logo
Plus   Neg
Share
Email

Brenntag Suspends FY20 Guidance - Quick Facts

Brenntag AG (BNTGF.PK) said its Board of Management has decided to suspend the forecast for fiscal 2020 due to the considerable uncertainty about the future effects of the COVID 19 pandemic on global economic performance. The company's business performance in the first quarter was not significantly impacted by the pandemic. With a few exceptions, the Brenntag sites are currently fully operational, the company stated.

The Group noted that it has a high level of liquidity and access to extensive, contractually agreed credit facilities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT